1-Benzyl-3,3-difluoropiperidine-4,4-diol - CAS 1067914-81-1
Catalog: |
BB001922 |
Product Name: |
1-Benzyl-3,3-difluoropiperidine-4,4-diol |
CAS: |
1067914-81-1 |
Synonyms: |
3,3-difluoro-1-(phenylmethyl)piperidine-4,4-diol; 1-benzyl-3,3-difluoropiperidine-4,4-diol |
IUPAC Name: | 1-benzyl-3,3-difluoropiperidine-4,4-diol |
Description: | 1-Benzyl-3,3-difluoropiperidine-4,4-diol (CAS# 1067914-81-1) is a useful research chemical. |
Molecular Weight: | 243.25 |
Molecular Formula: | C12H15F2NO2 |
Canonical SMILES: | C1CN(CC(C1(O)O)(F)F)CC2=CC=CC=C2 |
InChI: | InChI=1S/C12H15F2NO2/c13-11(14)9-15(7-6-12(11,16)17)8-10-4-2-1-3-5-10/h1-5,16-17H,6-9H2 |
InChI Key: | VUYVXSSPDOWKFE-UHFFFAOYSA-N |
Storage: | Sealed in dry, Room Temperature |
LogP: | 1.14640 |
Publication Number | Title | Priority Date |
WO-2019196622-A1 | 5-substituted difluoropiperidine compound capable of passing through blood-brain barrier | 20180409 |
EP-3778589-A1 | 5-substituted difluoropiperidine compound capable of passing through blood-brain barrier | 20180409 |
WO-2019196619-A1 | Quinazoline derivative salt-form crystal form, and preparation method therefor and application thereof | 20180408 |
EP-3544610-A1 | Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders | 20161122 |
US-2019298725-A1 | Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders | 20161122 |
Complexity: | 265 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 243.10708505 |
Formal Charge: | 0 |
Heavy Atom Count: | 17 |
Hydrogen Bond Acceptor Count: | 5 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 243.10708505 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 43.7 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS